| Field | Specification |
|---|---|
| Target | |
| Species | |
| Reactivity | |
| Applications | |
| Assay type | |
| Sample type(s) | serum, plasma |
| Sensitivity | |
| Detection range | |
| Detection wavelength | |
| Assay time | |
| Catalog no. (Mfr.) | |
| Main SKU |
Background
anti-nuclear Antibody (IgG) (ANA Ab (IgG)) is a biological molecule commonly studied in others research. Immunoglobulins are antibody proteins central to humoral immunity and antigen-specific responses.
Biological context
Researchers often monitor anti-nuclear Antibody (IgG) in serum and plasma to better understand themes such as mechanistic biology studies, biomarker-focused profiling, and disease-model research. In many model systems, measured levels can shift with physiology, experimental perturbation, or disease-associated changes, making careful biological interpretation important.
Interpreting changes in measured levels
Depending on sample matrix and study design, increases or decreases in anti-nuclear Antibody (IgG) may reflect differences in expression, secretion, turnover, or compartmentalization rather than a single mechanism. Interpretation is typically strengthened by evaluating related molecules (for example, complementary pathway markers and controls appropriate to the biological model) and by keeping pre-analytical variables consistent across groups.
Why ELISA data are widely used
ELISA is a common approach for quantitative measurement of proteins and biomarkers in complex samples, enabling comparisons across experimental groups and time points. When integrating results with other readouts, consider species biology, sample type, and the broader pathway context that anti-nuclear Antibody (IgG) participates in.
Can’t Find What You’re Looking For? We can help you source the best match or customize an ELISA solution for your study. Options may include alternative target synonyms, different species reactivity, sample type/matrix compatibility (serum/plasma/lysate/supernatant), assay format (sandwich/competitive), sensitivity/range, detection chemistry (colorimetric/fluorescent/chemiluminescent), plate format (pre-coated/uncoated, strips vs full plate), and bulk or custom packaging. Click Talk to a Scientist to submit a request form, email us at support@biohippo.com, or explore our Research Services for additional support. Our team will be in contact with you shortly.
Macrophage WDFY3 mitigates autoimmunity by enhancing efferocytosis and suppressing T cell activation in mice
X Wu, Z Wang, KR Croce, F Li, J Cui,Nature Communications,2025
Enhanced B-Cell Electroporation Efficiency via Inhibition of DNA Electroporation-Induced Apoptosis and Pyroptosis with Pan-Caspase Inhibitor
GL Yang, DG Wang, X Zhao, DL Hao, DP Liu,Molecular Therapy Methods & Clinical Development,2025
Exposure to Dietary Nitrite Exacerbates Lupus in MRL/lpr Mice by Enhancing Integrin Alpha M
Y Qiu, Q Zhang, X Yang, C Wen, Z He, M Wang,Inflammation,2025
Genetically engineered extracellular vesicles expressing decoy protein TACI provide a therapeutic effect in systemic lupus erythematosus mouse model
M Cai, F Tian, J Han, L Wang, S Hu, P Dong,Journal of Controlled Release,2025
Microbiota‐Derived Inosine Suppresses Systemic Autoimmunity via Restriction of B Cell Differentiation and Migration
L Gao, Y Zhang, Z Hu, S Chen, Q Wang,Advanced Science,2025
Single-cell analyses of intestinal epithelium reveal the dysregulation of gut immune microenvironment in systemic lupus erythematosus
Q Wang, Y Wu, L Ouyang, X Min, M Zheng,Journal of Translational Medicine,2025
Dysregulation in keratinocytes drives systemic lupus erythematosus onset
J Tian, L Shi, D Zhang, X Yao, M Zhao,Cellular & Molecular Immunology,2025
Characterization of Dendritic Cells and Myeloid-Derived Suppressor Cells Expressing Major Histocompatibility Complex Class II in Secondary Lymphoid Organs in Systemic Lupus Erythematosus-Prone Mice
FR Uribe, F González-Martínez,International Journal of Molecular Sciences,2024
TM9SF1 expression correlates with autoimmune disease activity and regulates antibody production through mTOR-dependent autophagy
J Xiao, Z Zhao, F Zhou, J Xiong, Z Yang,BMC medicine,2024
A rationally designed CD19 monoclonal antibody-triptolide conjugate for the treatment of systemic lupus erythematosus
L Wang, H Yin, J Jiang, Q Li, C Gao, W Li,Acta Pharmaceutica Sinica B,2024
Jieduquyuziyin prescription attenuates the side effect of prednisone through regulating gut microbiota when in the combination with prednisone treat MRL/lpr mice
Z Zhu,Journal of Traditional and Complementary Medicine,2024
Deletion of the Mitochondrial Membrane Protein Fam210b Is Associated with the Development of Systemic Lupus Erythematosus
Y Xu,International Journal of Molecular Sciences,2024
Podocyte SIRPα reduction aggravates lupus nephritis via promoting T cell inflammatory responses
B Qian,Cell reports,2024
Microplastics exposure induced and exacerbated the development of systemic lupus erythematosus in mice
H Chen,The Science of the total environment,2023
IL-38, a potential therapeutic agent for lupus, inhibits lupus progression
WD Xu,Inflammation research,2023
YY1 alleviates lupus nephritis-induced renal injury by reducing the Th17/Treg cell ratio via the IFN-γ/Fra2 axis
B Wang,Laboratory investigation,2023
Endogenous retrovirus promotes the aberrant T cell differentiation in systemic lupus erythematosus via RIG-I pathway
R Patil,/,2024
Gut microbiota mediated the effects of high relative humidity on lupus in female MRL/lpr mice
C Wang,Advances in rheumatology,2023
Simvastatin Reduces NETosis to Attenuate Severe Asthma by Inhibiting PAD4 Expression
YR Chen,Oxidative medicine and cellular longevity,2023
LncRNA IL21‐AS1 interacts with hnRNPU protein to promote IL21 overexpression and aberrant differentiation of Tfh cells in systemic lupus erythematosus
L Liu,Clinical and translational medicine,2022
Anti-Inflammatory Effect of Korean Propolis on Helicobacter pylori-Infected Gastric Mucosal Injury Mice Model
MY Song,Nutrients,2022
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
D Sridaran,Nature communications,2022
GDF-15: A Potential Biomarker and Therapeutic Target in Systemic Lupus Erythematosus
WD Xu,Frontiers in immunology,2022
Gut microbiota mediated the therapeutic efficacies and the side effects of prednisone in the treatment of MRL/lpr mice
M Wang,Arthritis research & therapy,2021
Reshaping the murine immunoglobulin heavy chain repertoire with bovine DH genes
D Yu,Immunology,2021
A novel mouse model for checkpoint inhibitor-induced adverse events
K Adam,Plos one,2021
Bifidobacterium breve M‐16V alters the gut microbiota to alleviate OVA‐induced food allergy through IL‐33/ST2 signal pathway
N Li,J. Cell. Physiol.,2020
Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance
Dongdong Fu, et al,Bmc Nephrology,2019
RNAi Silencing of HIF-1α Ameliorates Lupus Development in MRL/lpr Mice
Wei Zhao.et al,Inflammation,2018
Basophil Activation-Dependent Autoantibody and Interleukin-17 Production Exacerbate Systemic Lupus Erythematosus
Pan Q.et al,Front Immunol.,2017
Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
Yan SX.et al,Acta Pharmacol Sin.,2015